Fecal specimens from 223 subjects were evaluated for the presence of Clostridium difficile by use of a selective medium developed in our laboratory and for the presence of C. difficile cytotoxin. C. difficile and cytotoxin were detected in 89 and 83%, respectively, of patients with antimicrobial agent-associated pseudomembranous colitis (PMC). In patients in whom PMC was not documented, C.
ed as a cause of antimicrobial agent-associated colitis or diarrhea in humans (2, 5, 11) and a cause of antimicrobial-associated ileocecitis in Syrian hamsters (3, 6 ). We have previously described a selective and differential medium for the isolation of C. difficile from feces (8) , have subsequently studied a large number of subjects (most of whom had diarrhea related to antimicrobial therapy) for the presence of C. difficile in their feces with this medium, and assayed their feces for the presence of C. difficile cytotoxin.
MATERIALS AND METHODS
Physicians at the V.A. Wadsworth Medical Center and in other hospitals in the western United States were requested to send fecal specimens from patients with diarrhea thought to be due to antimicrobial therapy. Healthy individuals and patients who were receiving antimicrobial therapy but did not have diarrhea were also studied. A majority of the fecal specimens were frozen after collection and later shipped to our laboratory on dry ice for culture and cytotoxin assay; all specimens were collected before administration of oral vancomycin. Patients examination of a rectal biopsy specimen in the absence of plaques. If neither plaques nor inflammation were detected by sigmoidoscopy, then the patient was considered to have diarrhea without colitis.
The methods used to culture feces for C. difficile (8) and assay for cytotoxin (10) have been described previously. In all except three instances, the cytotoxin assay was performed on an initial 1:10 dilution of the fecal specimen. The results of the cytotoxin assay were expressed as the reciprocal of the highest dilution of feces that caused rounding of 50o of HeLa or human amnion cells in culture after 24 h of incubation. The dilution (1:20) resulting from inoculation of a sample into tissue culture medium was included in the calculation of the cytotoxin titer; 1:200 is the lowest detectable titer for specimens that were diluted 1:10 initially.
RESULTS
Fecal specimens from a total of 223 patients or healthy individuals were evaluated. The clinical diagnosis and the results of culture and cytotoxin assay are shown in Table 1 from feces. These three culture-negative but cytotoxin-positive specimens were from a patient with toxic megacolon related to therapy with ampicillin, clindamycin, and erythromycin; from a patient who had been treated with sulfasalazine for Crohn's disease; and from a patient with leukemia who was undergoing induction chemotherapy and had received clindamycin and moxalactam. These three specimens were of such small quantity that it was not possible to repeat the culture. The patients with antimicrobial-associated diarrhea were also evaluated as to the agent thought to have induced diarrhea; the results of this analysis for 142 patients are shown in Table  2 . Because penicillins, cephalosporins (and cephamycins), and lincosamides (lincomycin and clindamycin) are the most frequently reported causes of PMC and C. difficile-induced diarrhea (4) , data for patients who received single agent therapy with one of these groups of antimicrobial agents are shown in Table 3 . The incidence of positive culture for C. difficile in each of these three groups was not different by x2 analysis.
Data for the 13 patients who did not have diarrhea and received antimicrobial therapy are shown in Table 4 . DISCUSSION The most frequent association between the presence of C. difficile and its cytotoxin and antimicrobial-associated diarrhea is in patients with PMC ( (4) . As shown in Table 1 , a wide range in counts of C. difficile was noted in all groups of patients. We found that freezing substantially reduces the counts of C. difficile present in feces and in broth culture; the lack of uniformity of counts probably reflects the fact that many of our specimens had been frozen before culture.
Cytotoxin was detected in 21% of patients with antimicrobial-associated diarrhea and in whom PMC was not diagnosed. The titers of cytotoxin were not appreciably different among the various groups of patients (Table 1) . It is evident that the cytotoxin may have been present in additional patients in low titer; optimal cytotoxin assays would involve retesting of negative specimens in either undiluted or at a 1:2 dilution. A second toxin of C. difficile, which possesses the characteristics of an enterotoxin, has recently been described (1, 4) . Some investigators have questioned the importance of cytotoxin as a mediator of disease, in that both the cytotoxin and C. difficile can be detected in the feces of some healthy adults (12) and in a high percentage of healthy neonates and infants (14, 15) ; in addition, patients who receive antibiotics and who do not have diarrhea may have C. difficile and cytotoxin in their feces. We found C. difficile in 46% and cytotoxin in 25% of a small number of antibiotic recipients who did not have diarrhea (Table 1) . It is interesting that most of these individuals had been treated with cefoxitin (Table 4) . Cefoxitin is a component of the selective culture medium used in this study and is relatively inactive against C. difficile (9) .
As shown in Table 2 The diagnosis of C. difficile-induced diarrhea is currently a problem because of the lack of specificity of both culture and cytotoxin assay. The presence of colonic plaques or of a pseudomembrane is associated with C. difficile in 90% or more cases; because patients with PMC and C. difficile almost invariably respond to therapy with oral vancomycin (5), the demonstration of colonic plaques or of a pseudomembrane appears to be reasonably specific for C. difficileinduced disease. For patients with antimicrobial-induced diarrhea and in whom PMC cannot be documented, we have chosen to give a trial of oral vancomycin if such therapy is warranted on clinical grounds (7) and if either the culture or cytotoxin assay is positive. Until a highly specific and sensitive diagnostic test is developed, the diagnosis of C. difficileinduced diarrhea should be based on the clinical setting (presence of diarrhea that can reasonably be attributed to therapy with an antimicrobial agent), laboratory studies (positive culture or cytotoxin assay), endoscopy or barium enema (plaques or pseudomembrane), and the response to oral vancomycin if such therapy is indicated.
